Our broad aim is to define all of the signal transduction proteins that are part of the EpoR signaling complex and that are activated by Epo- stimulation, and to define their roles in controlling cell proliferation, erythroid differentiation, and prevention of apoptosis. An EpoR missing the C-terminal 100 amino acids supports Epo-dependent proliferation of Ba/F3 cells, yet several signal transduction proteins, particularly PI-3 kinase and SH-PTP1, are activated by more distal segments of the receptor. Presumably these and other signaling proteins are essential for erythroid differentiation and/or prevention of apoptosis. We showed that at least one protein-tyrosine kinase additional to JAK2 is involved in signaling by the EpoR, and we want to identify this kinase and determine its functions. We also showed that Y479 contains the principal binding site for PI-3 kinase and is essential for activation of MAP kinase, and we want to determine the function of these signaling proteins for differentiation of erythroid progenitors in vitro and in living mice. We showed that activation of the KIT receptor protein-tyrosine kinase induces tyrosine phosphorylation of the EpoR and that the EpoR is essential for KIT signaling in one cell line; thus, we want to determine how KIT signals through the EpoR. In several systems IGF-1 synergizes with Epo for erythroid differentiation, and we want to test whether the IGF-1 receptor, like KIT, signals through the EpoR. To accomplish these goals, we will generate a battery of EpoRs with specific mutations in their cytosolic domains; one focus will be on the extended Box 2 region essential for cell proliferation and KIT binding but not for JAK2 activation. In vitro and intact cell studies will determine sites necessary for binding and/or activation of specific signal transduction proteins. By expressing mutant receptors in a number of cell lines, in several types of primary erythroid progenitor cells, and, importantly in living mice in place of the normal EpoR, we can determine which EpoR segments are essential for preventing apoptosis, triggering cell proliferation, and inducing erythroid differentiation. Functions of these candidate proteins will be established by expressing or overexpressing wild-type or mutant proteins in cells expressing wild-type or mutant EpoRs. As part of these studies, we will generate mice in which one or both copies of the EpoR are replaced by mutants unable to bind and activate SH-PTP1 or PI-3 kinase.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL032262-19
Application #
6336641
Study Section
Project Start
2000-07-01
Project End
2001-06-30
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
19
Fiscal Year
2000
Total Cost
$305,316
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Blaser, Bradley W; Zon, Leonard I (2018) Making HSCs in vitro: don't forget the hemogenic endothelium. Blood 132:1372-1378
Kafina, Martin D; Paw, Barry H (2018) Using the Zebrafish as an Approach to Examine the Mechanisms of Vertebrate Erythropoiesis. Methods Mol Biol 1698:11-36
Clement, Kendell; Farouni, Rick; Bauer, Daniel E et al. (2018) AmpUMI: design and analysis of unique molecular identifiers for deep amplicon sequencing. Bioinformatics 34:i202-i210
Liu, Frances D; Tam, Kimberley; Pishesha, Novalia et al. (2018) Improving hematopoietic recovery through modeling and modulation of the mesenchymal stromal cell secretome. Stem Cell Res Ther 9:268
Huang, Nai-Jia; Lin, Ying-Cing; Lin, Chung-Yueh et al. (2018) Enhanced phosphocholine metabolism is essential for terminal erythropoiesis. Blood 131:2955-2966
Schoonenberg, Vivien A C; Cole, Mitchel A; Yao, Qiuming et al. (2018) CRISPRO: identification of functional protein coding sequences based on genome editing dense mutagenesis. Genome Biol 19:169
Lessard, Samuel; Beaudoin, Mélissa; Orkin, Stuart H et al. (2018) 14q32 and let-7 microRNAs regulate transcriptional networks in fetal and adult human erythroblasts. Hum Mol Genet 27:1411-1420
Esrick, Erica B; Bauer, Daniel E (2018) Genetic therapies for sickle cell disease. Semin Hematol 55:76-86
Yien, Yvette Y; Shi, Jiahai; Chen, Caiyong et al. (2018) FAM210B is an erythropoietin target and regulates erythroid heme synthesis by controlling mitochondrial iron import and ferrochelatase activity. J Biol Chem 293:19797-19811
Wattrus, Samuel J; Zon, Leonard I (2018) Stem cell safe harbor: the hematopoietic stem cell niche in zebrafish. Blood Adv 2:3063-3069

Showing the most recent 10 out of 215 publications